Dr. Enrique Seoane-Vazquez

Enrique Seoane-Vazquez, PhD is professor in pharmaceutical economic, regulation, and policy at Chapman University School of Pharmacy. He holds a PhD in Social and Administrative Pharmacy from the University of Minnesota and a BS in Economics from the University of Santiago. His previous work experience includes positions as Professor at the School of Pharmacy-Boston, Massachusetts College of Pharmacy and Health Sciences. Assistant Professor at the  Ohio State University, Colleges of Pharmacy and Public Health; and Research Fellow at the PRIME Institute, University of Minnesota, College of Pharmacy.

Research projects focus on prices of drugs in the US and other countries, intellectual property regulation of pharmaceuticals, and FDA policy and regulation. Seoane conducted more than 40 research projects for a variety of sponsors, including the Agency for Healthcare Research and Quality, Arnold Ventures, the Food and Drug Administration, the Kaiser Family Foundation, the Robert Wood Johnson Foundation, the World Bank, and the World Health Organization. In 2004, he served as the pharmacy expert in the Ohio Commission to Reform Medicaid, Columbus of the Ohio Department of Job and Family Services. He also conducted research for governments, organizations, and associations of a dozen countries. Dr. Seoane published more than 70 articles and 125 abstracts in reference journals, including the New England Journal of Medicine, the American Journal of Cardiology, PLoS One, Health Policy, and Value in Health. He has given more than 300 national and international presentations in his areas of expertise.

Dr. Seoane is the past-Chair of the Drug Policy and Pharmaceutical Services Committee of the American Public Health Association, an active member of the American Pharmacist Association, the Academy of Managed Care Pharmacy, the International Health Economists Association, and the International Society for Pharmacoeconomics and Outcomes Research.

Research Interests

Seoane's areas of research interest relate to pharmaceutical economics, regulation and policy at the national and international levels. Seoane combines an in-depth knowledge of FDA and state regulation and pharmacy practice and extensive experience analyzing FDA’s regulatory actions. He has extensive experience studying the generic drug market, drug utilization, prices and reimbursement, substitution patterns and drug safety using electronic medical records and large administrative claims datasets.

Seoane has extensive experience in the area of health economics and outcomes research, and assessing the cost-effectiveness of medications and health care interventions to improve patient-level health outcomes while containing the cost of provision of care.